- 3.4Impact Factor
- 9.9CiteScore
- 19 daysTime to First Decision
Vaccines, Volume 9, Issue 12
2021 December - 137 articles
Cover Story: The scarcity of alternative therapeutics against viral infections as efficient as vaccines makes them essential in such areas as animal care. Whole-pathogen inactivated vaccines present substantial biosafety and handling advantages and thus a higher market acceptance in the animal production industry, including in aquaculture. Viral nervous necrosis (VNN) caused by the nervous necrosis virus (NNV) affects a broad range of primarily marine fish species, with mass mortality rates among larvae and juveniles. Its genetic diversification may hinder the effective implementation of vaccines. The present study describes different rapid inactivation procedures for developing an inactivated vaccine against a new NNV isolate confirmed to possess deadly effects upon the European seabass (Dicentrarchus labrax), an important farmed fish species. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

